FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Hans Tillmann

Research Profile

Chemicals & Drugs

Living Beings

Disorders

Co-author Network

Publications

TOP 3
Melanie E Garrett; Michael A Hauser; Cynthia A Moylan; Herbert Pang; Manal F Abdelmalek; Allison Ashley-Koch; Anna Mae Diehl; Hans L Tillmann
IL28B rs12979860 is not associated with histologic features of NAFLD in a cohort of Caucasian North American patients.
Solveig Tenckhoff; Fritz Bredeek; Eric S Daar; Sharyne Donfield; Thorsten Kaiser; Alice Lail; Erika Menius; Joachim Mössner; Hans L Tillmann
Role of GB virus C in HIV-1-infected and hepatitis C virus-infected hemophiliac children and adolescents.
Henning Pflugrad; Hans L Tillmann; Xiaoqi Q Ding; Karin Weissenborn
Neuroinflammation in HCV-infection - peril or protection?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Hans Tillmann (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Melanie E Garrett; Michael A Hauser; Cynthia A Moylan; Herbert Pang; Manal F Abdelmalek; Allison Ashley-Koch; Anna Mae Diehl; Hans L Tillmann
IL28B rs12979860 is not associated with histologic features of NAFLD in a cohort of Caucasian North American patients.
Journal of hepatology 2013;58(2):402-3.
2012: Solveig Tenckhoff; Fritz Bredeek; Eric S Daar; Sharyne Donfield; Thorsten Kaiser; Alice Lail; Erika Menius; Joachim Mössner; Hans L Tillmann
Role of GB virus C in HIV-1-infected and hepatitis C virus-infected hemophiliac children and adolescents.
Journal of acquired immune deficiency syndromes (1999) 2012;61(2):243-8.
2012: Henning Pflugrad; Hans L Tillmann; Xiaoqi Q Ding; Karin Weissenborn
Neuroinflammation in HCV-infection - peril or protection?
Journal of hepatology 2012;57(4):921-2; author reply 923-4.
2012: Benjamin Heidrich; Ramazan Idilman; Gökhan Kabaçam; Michael P Manns; Regina Raupach; Andrzej Taranta; Hans L Tillmann; A Mithat Bozdayi; Hakan Bozkaya; Birgit Bremer; Katja Deterding; Cihan Yurdaydın; Behrend J Zacher; Kalliopi Zachou; Oguz Onder; Beatriz C Serrano; Heiner Wedemeyer
HBeAg-positive hepatitis delta: virological patterns and clinical long-term outcome.
Liver international : official journal of the International Association for the Study of the Liver 2012;32(9):1415-25.
2012: Kinan Rifai; Christian P Strassburg; Heiner Wedemeyer; Johannes Wiegand; Johannes Hadem; J Klempnauer; Michael P Manns; S Pischke; Andrej Potthoff; Hans L Tillmann
Gender differences in patient receiving liver transplantation for viral hepatitis.
Zeitschrift für Gastroenterologie 2012;50(8):760-5.
2012: Paul J Clark; Jacques Fellay; Dongliang Ge; David B Goldstein; Zachary Goodman; Stephen A Harrison; John G McHutchison; Susanna Naggie; Stephanie Noviello; Keyur Patel; Lisa Pedicone; Kevin Shianna; Mark S Sulkowski; Alexander J Thompson; Hans L Tillmann; Thomas J Urban; David M Vock; Mingfu Zhu; Qianqian Zhu; Nezam Afdhal; Janice K Albrecht; Andrew J Muir
The association of genetic variants with hepatic steatosis in patients with genotype 1 chronic hepatitis C infection.
Digestive diseases and sciences 2012;57(8):2213-21.
2012: Johannes Wiegand; C Trepo; M Kühne; Joachim Mössner; P Pradat; Hans L Tillmann
Different patterns of decompensation in patients with alcoholic vs. non-alcoholic liver cirrhosis.
Alimentary pharmacology & therapeutics 2012;35(12):1443-50.
2012: P J Clark; R Esteban; Jacques Fellay; D Ge; David B Goldstein; S A Harrison; Paul Y Kwo; John G McHutchison; Andrew J Muir; S Naggie; S Noviello; Keyur Patel; Lisa Pedicone; K Shianna; Mark S Sulkowski; A J Thompson; Hans L Tillmann; T J Urban; D M Vock; M Zhu; Q Zhu; Nezam H Afdhal; Janice K Albrecht
Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response.
Journal of viral hepatitis 2012;19(5):332-40.
2012: A B Jazwinski; S Naggie; A J Thompson; Hans L Tillmann; P J Clark; Keyur Patel
Elevated serum CK18 levels in chronic hepatitis C patients are associated with advanced fibrosis but not steatosis.
Journal of viral hepatitis 2012;19(4):278-82.
2012: Hans L Tillmann; Kalliopi Zachou; George N Dalekos
Management of severe acute to fulminant hepatitis B: to treat or not to treat or when to treat?
Liver international : official journal of the International Association for the Study of the Liver 2012;32(4):544-53.
2012: Alexander J Thompson; Hans L Tillmann; Thomas J Urban; Mingfu Zhu; Qianqian Zhu; Susanna Naggie; Stephanie Noviello; Keyur Patel; Lisa Pedicone; F Fred Poordad; Kevin V Shianna; Mitchell L Shiffman; Abanish Singh; Mark S Sulkowski; Nezam H Afdhal; Janice K Albrecht; Clifford A Brass; Paul J Clark; Rafael Esteban; Jacques Fellay; Greg W Galler; Dongliang Ge; David B Goldstein; Ira M Jacobson; John W King; Paul Y Kwo; Eric J Lawitz; Jonathan McCone; John G McHutchison; Andrew J Muir
Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patients.
Journal of hepatology 2012;56(2):313-9.
2011: Hans L Tillmann; Paul J Clark; Stephen D Gardner; CD Guy; Xiang Qian Lao; Josephine H Li; John G McHutchison; Andrew J Muir; Keyur Patel; Alexander Thompson; Jeanette J McCarthy
Beneficial IL28B genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis C.
Journal of hepatology 2011;55(6):1195-200.
2011: María J Gómara; Aurora Casanovas; Leticia Fernández; Teresa Pérez; Solveig Tenckhoff; Hans L Tillmann; Isabel Haro
Diagnostic value of anti-GBV-C antibodies in HIV-infected patients.
Chemical biology & drug design 2011;78(2):277-82.
2011: T Karlas; J Hartmann; A Weimann; M Maier; M Bartels; S Jonas; J Mössner; T Berg; Hans L Tillmann; J Wiegand
Prevention of lamivudine-resistant hepatitis B recurrence after liver transplantation with entecavir plus tenofovir combination therapy and perioperative hepatitis B immunoglobulin only.
Transplant infectious disease : an official journal of the Transplantation Society 2011;13(3):299-302.
2011: T F Karlas; C Pfrepper; Jonas Rosendahl; Christoph Benckert; Christian Wittekind; S Jonas; Joachim Moessner; Michael Tröltzsch; Hans L Tillmann; T Berg; Volker Keim; J Wiegand
Acoustic radiation force impulse (ARFI) elastography in acute liver failure: necrosis mimics cirrhosis.
Zeitschrift für Gastroenterologie 2011;49(4):443-8.
2011: Hans L Tillmann; M Wiese; Y Braun; Johannes Wiegand; S Tenckhoff; J Mössner; Michael P Manns; Karin Weissenborn
Quality of life in patients with various liver diseases: patients with HCV show greater mental impairment, while patients with PBC have greater physical impairment.
Journal of viral hepatitis 2011;18(4):252-61.
2011: Martin Bokemeyer; X-Q Ding; A Goldbecker; P Raab; M Heeren; D Arvanitis; Hans L Tillmann; Heinrich Lanfermann; Karin Weissenborn
Evidence for neuroinflammation and neuroprotection in HCV infection-associated encephalopathy.
Gut 2011;60(3):370-7.
2011: Alexander J Thompson; Rosanna Santoro; Valeria Piazzolla; Paul J Clark; Susanna Naggie; Hans L Tillmann; Keyur Patel; Andrew J Muir; Kevin V Shianna; Leonardo Mottola; Daniela Petruzzellis; Mario Romano; Fernando Sogari; Domenico Facciorusso; David B Goldstein; John G McHutchison; alessandra mangia
Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR.
Hepatology (Baltimore, Md.) 2011;53(2):389-95.
2011: Jerzy Jaroszewicz; Michael P Manns; Antoaneta Markova; Sandra Schulz; Hans L Tillmann; Heiner Wedemeyer; Karsten Wursthorn; C-Thomas Bock; Katja Deterding; Huy Ho; Markus Cornberg
Hepatitis B surface antigen (HBsAg) decrease and serum interferon-inducible protein-10 levels as predictive markers for HBsAg loss during treatment with nucleoside/nucleotide analogues.
Antiviral therapy 2011;16(6):915-24.
2011: Derek D Cyr; Joseph E Lucas; Paul J Clark; John G McHutchison; M Arthur Moseley; Keyur Patel; Alexander Thompson; J Will Thompson; Hans L Tillmann; Jeanette J McCarthy
Characterization of serum proteins associated with IL28B genotype among patients with chronic hepatitis C.
PloS one 2011;6(7):e21854.
2010: Alexander J Thompson; Andrew J Muir; Mark S Sulkowski; Keyur Patel; Hans L Tillmann; Paul J Clark; Susanna Naggie; Jacques Fellay; Dongliang Ge; Jeanette J McCarthy; David B Goldstein; John G McHutchison
Hepatitis C trials that combine investigational agents with pegylated interferon should be stratified by interleukin-28B genotype.
Hepatology (Baltimore, Md.) 2010;52(6):2243-4.
2010: Hans L Tillmann
The current status of thrombopoietins in the management of liver disease.
Gastroenterology & hepatology 2010;6(11):697-9.
2010: Hans Damerow; Lilly Yuen; Johannes Wiegand; Christine Walker; C-Thomas Bock; Stephen Locarnini; Hans L Tillmann
Mutation pattern of lamivudine resistance in relation to hepatitis B genotypes: hepatitis B genotypes differ in their lamivudine resistance associated mutation pattern.
Journal of medical virology 2010;82(11):1850-8.
2010: Hans L Tillmann; Alex J Thompson; Keyur Patel; Manfred Wiese; Hannelore Tenckhoff; Hans D Nischalke; Yuliya Lokhnygina; Ulrike Kullig; Uwe Göbel; Emanuela Capka; Johannes Wiegand; Ingolf Schiefke; Wolfgang Güthoff; Kurt Grüngreiff; Ingrid König; Ulrich Spengler; Jeanette McCarthy; Kevin V Shianna; David B Goldstein; John G McHutchison; Jörg Timm; Jacob Nattermann
A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice.
Gastroenterology 2010;139(5):1586-92, 1592.e1.
2010: Alexander J Thompson; Jacques Fellay; Keyur Patel; Hans L Tillmann; Susanna Naggie; Dongliang Ge; Thomas J Urban; Kevin V Shianna; Andrew J Muir; Michael W Fried; Nezam H Afdhal; David B Goldstein; John G McHutchison
Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia and decrease the need for ribavirin dose reduction.
Gastroenterology 2010;139(4):1181-9.
2010: J Wiegand; S Meya; V Schlaphoff; Michael P Manns; Joachim Mössner; Heiner Wedemeyer; Hans L Tillmann
HBV-specific T-cell responses in healthy seronegative sexual partners of patients with chronic HBV infection.
Journal of viral hepatitis 2010;17(9):631-9.
2010: Hans L Tillmann; John G McHutchison
Use of thrombopoietic agents for the thrombocytopenia of liver disease.
Seminars in hematology 2010;47(3):266-73.
2010: J Wiegand; T Karlas; I Schiefke; U Krasselt; T Bock; J Mössner; Hans L Tillmann
Resistance management in chronic hepatitis B complicated by renal failure.
Clinical nephrology 2010;74(1):53-8.
2010: Hans L Tillmann
Review.
Gastroenterology & hepatology 2010;6(6):387-8.
2010: Jeanette J McCarthy; Josephine H Li; Alexander Thompson; Sunil Suchindran; Xiang Qian Lao; Keyur Patel; Hans L Tillmann; Andrew J Muir; John G McHutchison
Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin.
Gastroenterology 2010;138(7):2307-14.
2009: B Heidrich; Katja Deterding; Hans L Tillmann; R Raupach; Michael P Manns; Heiner Wedemeyer
Virological and clinical characteristics of delta hepatitis in Central Europe.
Journal of viral hepatitis 2009;16(12):883-94.
2009: Johannes Wiegand; Keyur Patel; Hans L Tillmann
Does hepatitis B surface antigen kinetics, including both decline and reaching a threshold, improve prediction of response?
Hepatology (Baltimore, Md.) 2009;50(4):1314; author reply 1314.
2009: J Wiegand; B Luz; A-K Mengelkamp; R Moog; J Koscielny; I Halm-Heinrich; C Susemihl; F Bentzien; J Diekmann; D Wernet; R Karger; K Angert; A Schmitt-Thomssen; V Kiefel; K Lutter; R Hesse; R Kätzel; A Opitz; J Luhm; D Barz; U Leib; G Matthes; Hans L Tillmann
Autologous blood donor screening indicated a lower prevalence of viral hepatitis in East vs West Germany: epidemiological benefit from established health resources.
Journal of viral hepatitis 2009;16(10):743-8.
2009: S Heringlake; A Schütte; P Flemming; Wolff Schmiegel; M P Manns; Hans L Tillmann
Presumed cryptogenic liver disease in Germany: High prevalence of autoantibody-negative autoimmune hepatitis, low prevalence of NASH, no evidence for occult viral etiology.
Zeitschrift für Gastroenterologie 2009;47(5):417-23.
2009: Karin Weissenborn; Anita B Tryc; Meike Heeren; Hans Worthmann; Henning Pflugrad; Georg Berding; Martin Bokemeyer; Hans L Tillmann; Annemarie Goldbecker
Hepatitis C virus infection and the brain.
Metabolic brain disease 2009;24(1):197-210.
2009: Hans L Tillmann; Keyur Patel; John McHutchison
Hepatitis B virus viral load and treatment decision.
Hepatology (Baltimore, Md.) 2009;49(2):699; author reply 701-2.
2009: Hans L Tillmann; Keyur Patel; John G McHutchison
Role of growth factors and thrombopoietic agents in the treatment of chronic hepatitis C.
Current gastroenterology reports 2009;11(1):5-14.
2009: Thorsten Kaiser; Joachim Moessner; Keyur Patel; John G McHutchison; Hans L Tillmann
Life threatening liver disease during treatment with monoclonal antibodies.
BMJ (Clinical research ed.) 2009;338():b508.
2008: Maren Moenkemeyer; Reinhold E Schmidt; Heiner Wedemeyer; Hans L Tillmann; Hans Heiken
GBV-C coinfection is negatively correlated to Fas expression and Fas-mediated apoptosis in HIV-1 infected patients.
Journal of medical virology 2008;80(11):1933-40.
2008: Hans L Tillmann
The treatment of chronic hepatitis B: Focus on adefovir-like antivirals.
Therapeutics and clinical risk management 2008;4(4):797-802.
2008: J Wiegand; Joachim Mössner; Hans L Tillmann
[Diagnostics and therapy of chronic hepatitis B and C].
Der Internist 2008;49(7):817-29; quiz 830-1.
2008: Thorsten Kaiser; Hans C Damerow; Solveig Tenckhoff; Andrea Finger; Isabella Böttcher; Carsten Hafer; Anke Schwarz; Johann B Lüth; Hans Schmidt Gürtler; Giuseppe Colucci; Michael P Manns; Heiner Wedemeyer; Hans L Tillmann
Kinetics of hepatitis C viral RNA and HCV-antigen during dialysis sessions: evidence for differential viral load reduction on dialysis.
Journal of medical virology 2008;80(7):1195-201.
2008: Hans L Tillmann; Keyur Patel; John G McHutchison
GBV-C in HIV-HCV coinfection, low liver-related mortality but high overall mortality.
Gastroenterology 2008;134(7):2191; author reply 2191-2.
2008: J Girke; H Wedemeyer; J Wiegand; M P Manns; Hans L Tillmann
[Acute hepatitis B: is antiviral therapy indicated? Two case reports].
Deutsche medizinische Wochenschrift (1946) 2008;133(22):1178-82.
2008: S Lobstein; T Kaiser; U. Liebert; M Wojan; A Leichtle; Joachim Mössner; J Wiegand; Hans L Tillmann
Prevalence, aetiology and associated co-morbidities of elevated aminotransferases in a german cohort of orthopaedic surgery patients.
Zeitschrift für Gastroenterologie 2008;46(5):415-20.
2008: Hans L Tillmann; John G McHutchison
Telbivudine versus lamivudine in patients with chronic hepatitis B.
The New England journal of medicine 2008;358(14):1517; author reply 1517-8.
2008: Nazanin Hooman; Kinan Rifai; Johannes Hadem; Bernhard Vaske; Gunnar Philipp; Andrea Priess; Juergen Klempnauer; Hans L Tillmann; Michael P Manns; Jens Rosenau
Antibody to hepatitis B surface antigen trough levels and half-lives do not differ after intravenous and intramuscular hepatitis B immunoglobulin administration after liver transplantation.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2008;14(4):435-42.
2008: Johannes Hadem; Penelope Stiefel; Matthias J Bahr; Hans L Tillmann; Kinan Rifai; Jürgen Klempnauer; Heiner Wedemeyer; Michael P Manns; Andrea S Schneider
Prognostic implications of lactate, bilirubin, and etiology in German patients with acute liver failure.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2008;6(3):339-45.
2008: Sandra Ciesek; H Liermann; Johannes Hadem; Tim F Greten; Hans L Tillmann; Markus Cornberg; Nuray Aslan; Michael P Manns; Heiner Wedemeyer
Impaired TRAIL-dependent cytotoxicity of CD1c-positive dendritic cells in chronic hepatitis C virus infection.
Journal of viral hepatitis 2008;15(3):200-11.
2008: Sandra Ciesek; Fabian A Helfritz; Ulrich Lehmann; Thomas Becker; Christian P Strassburg; Michael Neipp; Ayse Ciner; Paraskevi Fytili; Hans L Tillmann; Michael Peter Manns; Heiner Wedemeyer
Persistence of occult hepatitis B after removal of the hepatitis B virus-infected liver.
The Journal of infectious diseases 2008;197(3):355-60.
2008: Hans L Tillmann; Alexander J V Thompson
Shall we treat all patients with hepatitis C, and if not, why? Certainly, injecting drug users must not be an exclusion criterion.
Digestion 2008;78(2-3):120-2.
2008: Johannes Wiegand; Heiner Wedemeyer; Andrea Finger; Benjamin Heidrich; Jens Rosenau; Gerd Michel; C-Thomas Bock; Michael P Manns; Hans L Tillmann
A decline in hepatitis B virus surface antigen (hbsag) predicts clearance, but does not correlate with quantitative hbeag or HBV DNA levels.
Antiviral therapy 2008;13(4):547-54.
2008: Johannes Wiegand; Dirk Hasenclever; Hans L Tillmann
Should treatment of hepatitis B depend on hepatitis B virus genotypes? A hypothesis generated from an explorative analysis of published evidence.
Antiviral therapy 2008;13(2):211-20.
2007: Julia Behrbohm; Matthias Neid; Ulrich Stölzel; Christian Wittekind; Johann Hauss; Hans L Tillmann
Improvement of multiple sclerosis on tacrolimus plus mycophenolate mofetil after liver transplantation. Clinical improvement of multiple sclerosis in a patient requiring liver transplantation for acute liver failure following interferon-beta therapy.
Transplant international : official journal of the European Society for Organ Transplantation 2007;20(12):1077-9.
2007: Hans L Tillmann
Does the presence of hepatic steatosis influence the efficacy of antiviral treatment in patients with hepatitis C?
Nature clinical practice. Gastroenterology & hepatology 2007;4(10):548-9.
2007: Anne Kubitschke; C Bader; Hans L Tillmann; Michael P Manns; S Kuhn; Heiner Wedemeyer
[Injuries from needles contaminated with hepatitis C virus: how high is the risk of seroconversion for medical personnel really?].
Der Internist 2007;48(10):1165-72.
2007: Hans L Tillmann
Screening for and treating hepatitis B virus in patients with HIV infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;45(5):633-6.
2007: Hans L Tillmann
Pradefovir, a liver-targeted prodrug of adefovir against HBV infection.
Current opinion in investigational drugs (London, England : 2000) 2007;8(8):682-90.
2007: Pierre Pradat; Hans L Tillmann; Silvia Sauleda; Jean Henrik Braconier; G Saracco; Mark Thursz; Robert Goldin; R Winkler; Alfredo Alberti; Juan Ignacio Esteban; Stephanos Hadziyannis; M Rizzetto; Howard Thomas; Michael P Manns; Christian Trepo
Long-term follow-up of the hepatitis C HENCORE cohort: response to therapy and occurrence of liver-related complications.
Journal of viral hepatitis 2007;14(8):556-63.
2007: Pierre Pradat; Nicolas Voirin; Hans L Tillmann; Michèle Chevallier; Christian Trépo
Progression to cirrhosis in hepatitis C patients: an age-dependent process.
Liver international : official journal of the International Association for the Study of the Liver 2007;27(3):335-9.
2007: Jens Rosenau; Therese Kreutz; Matthias Kujawa; Matthias J Bahr; Kinan Rifai; Nazanin Hooman; Andrea Finger; Gerd Michel; Björn Nashan; Ernst R Kuse; Jürgen Klempnauer; Hans L Tillmann; Michael P Manns
HBsAg level at time of liver transplantation determines HBsAg decrease and anti-HBs increase and affects HBV DNA decrease during early immunoglobulin administration.
Journal of hepatology 2007;46(4):635-44.
2007: Kinan Rifai; Heiner Wedemeyer; Jens Rosenau; Jürgen Klempnauer; Christian P Strassburg; Michael P Manns; Hans L Tillmann
Longer survival of liver transplant recipients with hepatitis virus coinfections.
Clinical transplantation 2007;21(2):258-64.
2007: Eugene R Schiff; Ching-Lung Lai; Stephanos Hadziyannis; Peter Neuhaus; Norah A Terrault; Massimo Colombo; Hans L Tillmann; Didier Samuel; Stefan Zeuzem; Jean-Pierre Villeneuve; Sarah Arterburn; Katyna Borroto-Esoda; Carol L Brosgart; Steven Chuck
Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: final long-term results.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2007;13(3):349-60.
2007: Jens Rosenau; Nazanin Hooman; Johannes Hadem; Kinan Rifai; Matthias J Bahr; Gunnar Philipp; Hans L Tillmann; Jürgen Klempnauer; Christian P Strassburg; Michael P Manns
Failure of hepatitis B vaccination with conventional HBsAg vaccine in patients with continuous HBIG prophylaxis after liver transplantation.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2007;13(3):367-73.
2007: J Wiegand; Joachim Mössner; Hans L Tillmann
[Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis].
Der Internist 2007;48(2):154-63.
2007: Hans L Tillmann; Mark Thursz
Hepatitis C virus infection--its role in pathogenesis.
The Journal of infectious diseases 2007;195(2):168-70.
2007: Hans L Tillmann
Antiviral therapy and resistance with hepatitis B virus infection.
World journal of gastroenterology : WJG 2007;13(1):125-40.
2007: Corinna Trebst; Heiner Wedemeyer; Michael P Manns; Hans L Tillmann; Anja Windhagen
Treatment of hepatitis C virus-associated inflammatory polyneuropathy with pegylated interferon-alpha and ribavirin.
European journal of gastroenterology & hepatology 2007;19(1):91-2.
2007: Anne Kubitschke; M J Bahr; Nuray Aslan; C Bader; Hans L Tillmann; Christoph Sarrazin; Tim F Greten; Johannes Wiegand; Michael P Manns; Heiner Wedemeyer
Induction of hepatitis C virus (HCV)-specific T cells by needle stick injury in the absence of HCV-viraemia.
European journal of clinical investigation 2007;37(1):54-64.
2006: Johannes Wiegand; Matthias Neid; T Kaiser; Christian Wittekind; Joachim Mössner; Hans L Tillmann; Ingolf Schiefke
Coexistence of autoimmune pancreatitis and primary biliary cirrhosis in a Caucasian patient - a rare cause of cholestasis.
Zeitschrift für Gastroenterologie 2006;44(12):1227-9.
2006: Katja Deterding; Björn Tegtmeyer; Markus Cornberg; Johannes Hadem; Andrej Potthoff; Klaus H W Böker; Hans L Tillmann; Michael P Manns; Heiner Wedemeyer
Hepatitis A virus infection suppresses hepatitis C virus replication and may lead to clearance of HCV.
Journal of hepatology 2006;45(6):770-8.
2006: Andrej Potthoff; Hans L Tillmann; Christoph Bara; Katja Deterding; Klaus Pethig; S Meyer; Axel Haverich; Klaus H W Böker; Michael P Manns; Heiner Wedemeyer
Improved outcome of chronic hepatitis B after heart transplantation by long-term antiviral therapy.
Journal of viral hepatitis 2006;13(11):734-41.
2006: Karin Weissenborn; Jochen C Ennen; Martin Bokemeyer; Björn Ahl; Ulrich Wurster; Hans L Tillmann; Corinna Trebst; Hartmut Hecker; Georg Berding
Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment.
Gut 2006;55(11):1624-30.
2006: Jens Rosenau; Nazanin Hooman; Kinan Rifai; Therese Solga; Hans L Tillmann; Edith Grzegowski; Björn Nashan; Jürgen Klempnauer; Christian P Strassburg; Heiner Wedemeyer; Michael P Manns
Hepatitis B virus immunization with an adjuvant containing vaccine after liver transplantation for hepatitis B-related disease: failure of humoral and cellular immune response.
Transplant international : official journal of the European Society for Organ Transplantation 2006;19(10):828-33.
2006: Hans L Tillmann; T Kaiser; C Claes; Reinhold E Schmidt; Michael P Manns; M Stoll
Differential influence of different hepatitis viruses on quality of life in HIV positive patients.
European journal of medical research 2006;11(9):381-5.
2006: Nuray Aslan; Cihan Yurdaydin; Johannes Wiegand; Tim F Greten; A Ciner; Manuela F Meyer; Hans Heiken; B Kuhlmann; T Kaiser; Hakan Bozkaya; Hans L Tillmann; A Mithat Bozdayi; Michael P Manns; Heiner Wedemeyer
Cytotoxic CD4 T cells in viral hepatitis.
Journal of viral hepatitis 2006;13(8):505-14.
2006: Hans L Tillmann
Lamivudine-resistant hepatitis B virus infection post-liver transplantation from a hepatitis B core antibody donor.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2006;6(8):1980; author reply 1981.
2006: Hans L Tillmann; Johannes Hadem; L Leifeld; Kalliopi Zachou; A Canbay; Christoph Eisenbach; I Graziadei; Jens Encke; H Schmidt; W Vogel; A Schneider; U Spengler; G Gerken; Georgios N Dalekos; Heiner Wedemeyer; Michael P Manns
Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience.
Journal of viral hepatitis 2006;13(4):256-63.
2006: W Zhang; Kathryn Chaloner; Hans L Tillmann; Carolyn F Williams; Jack T Stapleton
Effect of early and late GB virus C viraemia on survival of HIV-infected individuals: a meta-analysis.
HIV medicine 2006;7(3):173-80.
2006: Johannes Wiegand; T Kaiser; S Lobstein; F Brand; M Wojan; Ulrich Stölzel; U. Liebert; Joachim Mössner; Hans L Tillmann
Low prevalence of chronic hepatitis C, but high prevalence of elevated aminotransferases in a cohort of 2026 patients referred for orthopaedic surgery in the eastern part of Germany.
Zeitschrift für Gastroenterologie 2006;44(1):11-4.
2005: Hans L Tillmann; Thorsten Kaiser; Zoe Fox; Schlomo Staszewski; Francesco Antunes; Antonella d'Arminio Monforte; Pietro Vernazza; Andrew Hill; Ulrik B Dragsted; Jens D Lundgren
Impact of coinfection with HIV-1 and GB virus C in patients receiving a ritonavir-boosted HAART regimen: a substudy to the MaxCmin1 trial.
Journal of acquired immune deficiency syndromes (1999) 2005;40(3):378-80.
2005: Ruben R Plentz; Hans L Tillmann; Stefan Kubicka; Jörg S Bleck; Michael Gebel; Michael P Manns; K Lenhard Rudolph
Hepatocellular carcinoma and octreotide: treatment results in prospectively assigned patients with advanced tumor and cirrhosis stage.
Journal of gastroenterology and hepatology 2005;20(9):1422-8.
2005: Felix Gundling; Hans L Tillmann; O Schmidt; M Brennenstuhl; Andreas Nerlich; Wolfgang Schepp
[Severe intrahepatic cholestasis in a 66-year old male patient with medically treated atrial fibrillation].
Der Internist 2005;46(9):1038-42.
2005: Andrej Potthoff; Johannes Wiegand; J B Lüth; Heiner Wedemeyer; Michael P Manns; Hans L Tillmann
Superiority of standard interferon-alpha2b compared to pegylated interferon-alpha2b (12 kDa) in a hemodialysis patient with chronic hepatitis C?
Clinical nephrology 2005;63(3):232-5.
2005: Hans L Tillmann; Michael P Manns; K Lenhard Rudolph
Merging models of hepatitis C virus pathogenesis.
Seminars in liver disease 2005;25(1):84-92.
2005: Thorsten Kaiser; Hans L Tillmann
GB virus C infection: is there a clinical relevance for patients infected with the human immunodeficiency virus?
AIDS reviews 2005;7(1):3-12.
2005: Hans L Tillmann; Johannes Wiegand; Isabella Glomb; A Jelineck; Gaston Picchio; Heiner Wedemeyer; Michael P Manns
Diagnostic algorithm for chronic hepatitis C virus infection: role of the new HCV-core antigen assay.
Zeitschrift für Gastroenterologie 2005;43(1):11-6.
2004: Hans L Tillmann
Hepatitis C virus infection and the brain.
Metabolic brain disease 2004;19(3-4):351-6.
2004: Frauke Mattner; Hans L Tillmann
Proof of alleged transmission of hepatitis C virus by a conjunctival blood splash.
American journal of infection control 2004;32(6):375-6.
2004: Hans L Tillmann; Michael P Manns; C Claes; Hans Heiken; Reinhold E Schmidt; Matthias Stoll
GB virus C infection and quality of life in HIV-positive patients.
AIDS care 2004;16(6):736-43.
2004: Hubert E Blum; T Berg; Hans L Tillmann; Fritz von Weizsäcker
[Procedures for problematic situations with hepatitis B].
Zeitschrift für Gastroenterologie 2004;42(8):692-7.
2004: Johannes Wiegand; Elmar Jäckel; Markus Cornberg; Holger Hinrichsen; Manfred Dietrich; Julian Kroeger; Wolfgang P Fritsch; Anne Kubitschke; Nuray Aslan; Hans L Tillmann; Michael Peter Manns; Heiner Wedemeyer
Long-term follow-up after successful interferon therapy of acute hepatitis C.
Hepatology (Baltimore, Md.) 2004;40(1):98-107.
2004: Pierre Pradat; Marianne Maynard; Maria Buti; Pascale Berthillon; Gaston Picchio; Hans L Tillmann; Johannes Wiegand; Nicolas Voirin; Michael P Manns; Juan Ignacio Esteban; Michèle Martinot; Patrick Marcellin; Christian Trepo
The predictive value of core antigen testing for the management of hepatitis C patients receiving pegylated interferon/ribavirin treatment.
Journal of medical virology 2004;73(3):392-6.
2004: Marc Lehmann; Manuela F Meyer; Masyar Monazahian; Hans L Tillmann; Michael P Manns; Heiner Wedemeyer
High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection.
Journal of medical virology 2004;73(3):387-91.
2004: Johannes Wiegand; J J W Tischendorf; Björn Nashan; Jürgen Klempnauer; Peer Flemming; P Niemann; P Rohde; Michael P Manns; Christian Trautwein; Hans L Tillmann
Severe exacerbation of chronic hepatitis B after emergence of lamivudine resistance in a cirrhotic patient: immediate switch to adefovir dipivoxil appears to be indicated.
Zeitschrift für Gastroenterologie 2004;42(1):15-8.
2004: Heiner Wedemeyer; Markus Cornberg; B Tegtmeyer; H Frank; Hans L Tillmann; Michael P Manns
Isolated anti-HBV core phenotype in anti-HCV-positive patients is associated with hepatitis C virus replication.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2004;10(1):70-2.
2003: Peer Flemming; Hans L Tillmann; Hannelore Barg-Hock; Wolfram Kleeberger; Michael P Manns; Jürgen Klempnauer; Hans H Kreipe
Donor origin of de novo hepatocellular carcinoma in hepatic allografts.
Transplantation 2003;76(11):1625-7.
2003: Eugene R Schiff; Ching-Lung Lai; Stephanos Hadziyannis; Peter Neuhaus; Norah A Terrault; Massimo Colombo; Hans L Tillmann; Didier Samuel; Stefan Zeuzem; Leslie Lilly; Maria Rendina; Jean-Pierre Villeneuve; Nicole Lama; Craig James; Michael Wulfsohn; Hamid Namini; Christopher E Westland; Shelly Xiong; Gavin S Choy; Sally Van Doren; John Fry; Carol L Brosgart
Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patients.
Hepatology (Baltimore, Md.) 2003;38(6):1419-27.
2003: Peer Flemming; Hans L Tillmann; Hannelore Barg-Hock; Wolfram Kleeberger; Michael P Manns; Jürgen Klempnauer; Hans H Kreipe
Donor origin of de novo hepatocellular carcinoma in hepatic allografts.
Transplantation 2003;76(5):871-3.
2003: Hans L Tillmann; A Schwarz
[Virus associated glomerulonephritis].
Der Internist 2003;44(9):1098-106.
2003: Hans L Tillmann; Jürgen Klempnauer; Michael P Manns
Risks and benefits of nucleosides before and after liver transplantation.
Transplantation proceedings 2003;35(6):2086-7.
2003: Lars Zender; Sebastian Hutker; Christian Liedtke; Hans L Tillmann; Steffen Zender; Bettina Mundt; Morlen Waltemathe; Thomas Gosling; Peer Flemming; Nisar P Malek; Christian Trautwein; Michael Peter Manns; Florian Kuhnel; Stefan Kubicka
Caspase 8 small interfering RNA prevents acute liver failure in mice.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(13):7797-802.
2003: Hans L Tillmann; Michael P Manns
[Indications for liver transplantation].
Deutsche medizinische Wochenschrift (1946) 2003;128 Suppl 2():S104-6.
2003: C-Thomas Bock; Boris Buerke; Hans L Tillmann; Frank Tacke; Volker Kliem; Michael P Manns; Christian Trautwein
Relevance of hepatitis B core gene deletions in patients after kidney transplantation.
Gastroenterology 2003;124(7):1809-20.
2003: A Scott Muerhoff; Hans L Tillmann; Michael P Manns; George J Dawson; Suresh M Desai
GB virus C genotype determination in GB virus-C/HIV co-infected individuals.
Journal of medical virology 2003;70(1):141-9.
2003: Hans L Tillmann; C-Thomas Bock; Jörg S Bleck; Jens Rosenau; Klaus H W Böker; Hannelore Barg-Hock; Thomas Becker; Christian Trautwein; Jürgen Klempnauer; Peer Flemming; Michael P Manns
Successful treatment of fibrosing cholestatic hepatitis using adefovir dipivoxil in a patient with cirrhosis and renal insufficiency.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2003;9(2):191-6.
2003: Hans L Tillmann; Heiner Wedemeyer; Michael Peter Manns
Treatment of hepatitis B in special patient groups: hemodialysis, heart and renal transplant, fulminant hepatitis, hepatitis B virus reactivation.
Journal of hepatology 2003;39 Suppl 1():S206-11.
2003: Bettina Mundt; Florian Kühnel; Lars Zender; Yasmin Paul; Hans L Tillmann; Christian Trautwein; Michael Peter Manns; Stefan Kubicka
Involvement of TRAIL and its receptors in viral hepatitis.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2003;17(1):94-6.
2002: Andreas Teubner; Hans L Tillmann; Detlef Schuppan; Gitta Gericke; Michael P Manns; Ulrich Stölzel
[Prevalence of circulating autoantibodies in healthy individuals].
Medizinische Klinik (Munich, Germany : 1983) 2002;97(11):645-9.
2002: Cihan Yurdaydin; Hakan Bozkaya; Selim Gürel; Hans L Tillmann; Nuray Aslan; A Okçu-Heper; Esra Erden; Kendal Yalçin; Nevzat Iliman; Ozden Uzunalimoglu; Michael P Manns; A Mithat Bozdayi
Famciclovir treatment of chronic delta hepatitis.
Journal of hepatology 2002;37(2):266-71.
2002: Stefan Wiemann; Ande Satyanarayana; Martina Tsahuridu; Hans L Tillmann; Lars Zender; Jürgen Klempnauer; Peer Flemming; Sonia Franco; Maria A Blasco; Michael P Manns; K Lenhard Rudolph
Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2002;16(9):935-42.
2002: Hans Heiken; Matthias Stoll; Hans L Tillmann; M P Manns; RE Schmidt
[Helper cells, viral load, genetic factors, co-infections. Prognostic factors in HIV-1 infection].
MMW Fortschritte der Medizin 2002;144 Suppl 1():51-5.
2002: Hans L Tillmann; Matthias Stoll; Michael P Manns; Reinhold E Schmidt; Hans Heiken
Chemokine receptor polymorphisms and GB virus C status in HIV-positive patients.
AIDS (London, England) 2002;16(5):808-9.
2002: Hans L Tillmann; Christian Trautwein; C-Thomas Bock; Isabella Glomb; Martin Krüger; Klaus H W Böker; Jürgen Klempnauer; Peer Flemming; Michael P Manns
Lamivudine transiently reduces viral load and improves liver function in liver transplant recipients with fibrosing cholestatic hepatitis.
The American journal of gastroenterology 2002;97(3):777-8.
2002: Ulrich Stölzel; Detlef Schuppan; Hans L Tillmann; Michael P Manns; Andrea Tannapfel; Manfred O Doss; Thomas Zimmer; Erich Köstler
Autoimmunity and HCV infection in porphyria cutanea tarda: a controlled study.
Cellular and molecular biology (Noisy-le-Grand, France) 2002;48(1):43-7.
2002: C-Thomas Bock; Hans L Tillmann; Joseph Torresi; Jürgen Klempnauer; Stephen Locarnini; Michael P Manns; Christian Trautwein
Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation.
Gastroenterology 2002;122(2):264-73.
2001: Hans L Tillmann
Hepatitis C virus infection.
The New England journal of medicine 2001;345(19):1426; author reply 1427-8.
2001: Jens Rosenau; Hans L Tillmann; Matthias J Bahr; Christian Trautwein; Klaus H W Boeker; Björn Nashan; Jürgen Klempnauer; Michael P Manns
Successful hepatitis B reinfection prophylaxis with lamivudine and hepatitis B immune globulin in patients with positive HBV-DNA at time of liver transplantation.
Transplantation proceedings 2001;33(7-8):3637-8.
2001: Hans L Tillmann; Michael P Manns
GB virus-C infection in patients infected with the human immunodeficiency virus.
Antiviral research 2001;52(2):83-90.
2001: Hans L Tillmann; Hans Heiken; A Knapik-Botor; S Heringlake; J Ockenga; J C Wilber; B Goergen; J Detmer; M McMorrow; Matthias Stoll; Reinhold E Schmidt; Michael P Manns
Infection with GB virus C and reduced mortality among HIV-infected patients.
The New England journal of medicine 2001;345(10):715-24.
2001: Jens Rosenau; Matthias J Bahr; Hans L Tillmann; Christian Trautwein; Jürgen Klempnauer; Michael P Manns
Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation possible role of mutations in the YMDD motif prior to transplantation as a risk factor for reinfection.
Journal of hepatology 2001;34(6):895-902.
2001: Hans L Tillmann; Jens Rosenau; Christian Trautwein; Klaus H W Boeker; Michael P Manns
Successful orthotopic liver transplantation.
Gastroenterology 2001;120(6):1561-2.
2001: Hans L Tillmann; DF Chen; Christian Trautwein; Volker Kliem; A Grundey; A Berning-Haag; K Böker; Stefan Kubicka; LT Pastucha; W Stangel; Michael P Manns
Low frequency of HLA-DRB1*11 in hepatitis C virus induced end stage liver disease.
Gut 2001;48(5):714-8.
2001: Adji Widjaja; Heiner Wedemeyer; Hans L Tillmann; R Horn; Johann Ockenga; Elmar Jaeckel; Alexander von zur Mühlen; Michael P Manns; Georg Brabant
Hepatitis C and the leptin system: bound leptin levels are elevated in patients with hepatitis C and decrease during antiviral therapy.
Scandinavian journal of gastroenterology 2001;36(4):426-31.
2000: Johann Ockenga; Stephan C Bischoff; Hans L Tillmann; Kinan Rifai; Adji Widjaja; Klaus H W Böker; Michael P Manns; G Brabant
Elevated bound leptin correlates with energy expenditure in cirrhotics.
Gastroenterology 2000;119(6):1656-62.
2000: Franz-Christoph Bange; S Ruttkowski; M Kist; S Bereswill; D Meyer; Reinhold E Schmidt; Hans L Tillmann; Ingolf Schedel; Michael P Manns; Florian Gunzer
Clinical microbiological case: a 35-year-old HIV-positive man with intermittent fever and chronic diarrhea.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2000;6(11):613-5.
2000: Ulrich Stölzel; Detlef Schuppan; Hans L Tillmann; Michael P Manns; Andrea Tannapfel; Manfred O Doss; Thomas Zimmer; C Koszka; Erich Köstler
Autoantibodies in porphyria cutanea tarda: a controlled study.
Journal of hepatology 2000;33(5):858-9.
2000: Stefan Kubicka; K Lenhard Rudolph; M Hanke; MK Tietze; Hans L Tillmann; Christian Trautwein; Michael P Manns
Hepatocellular carcinoma in Germany: a retrospective epidemiological study from a low-endemic area.
Liver 2000;20(4):312-8.
2000: Sandrine Touzet; L Kraemer; Cyrille Colin; Pierre Pradat; D Lanoir; François Bailly; Rosa Cristina Coppola; Silvia Sauleda; Mark Thursz; Hans L Tillmann; Alfredo Alberti; Jean Henrik Braconier; Juan Ignacio Esteban; S J Hadziyannis; Michael P Manns; G Saracco; Howard Thomas; Christian Trépo
Epidemiology of hepatitis C virus infection in seven European Union countries: a critical analysis of the literature. HENCORE Group. (Hepatitis C European Network for Co-operative Research.
European journal of gastroenterology & hepatology 2000;12(6):667-78.
2000: Pierre Pradat; P Chossegros; François Bailly; P Pontisso; G Saracco; Silvia Sauleda; Mark Thursz; Hans L Tillmann; H Vlassopoulou; Alfredo Alberti; Jean Henrik Braconier; Juan Ignacio Esteban; Stephanos Hadziyannis; Michael P Manns; M Rizzetto; Howard Thomas; Christian Trépo
Comparison between three quantitative assays in patients with chronic hepatitis C and their relevance in the prediction of response to therapy.
Journal of viral hepatitis 2000;7(3):203-10.
2000: C-Thomas Bock; Nisar P Malek; Hans L Tillmann; Michael P Manns; Christian Trautwein
The enhancer I core region contributes to the replication level of hepatitis B virus in vivo and in vitro.
Journal of virology 2000;74(5):2193-202.
1999: Heiner Wedemeyer; Klaus H W Böker; Klaus Pethig; DR Petzold; Peer Flemming; Hans L Tillmann; J Vollmar; M Bastürk; E Goldmann; K E Griffin; Axel Haverich; Michael P Manns
Famciclovir treatment of chronic hepatitis B in heart transplant recipients: a prospective trial.
Transplantation 1999;68(10):1503-11.
1999: Hans L Tillmann; Elmar Jäckel; Michael P Manns
Liver transplantation in autoimmune liver disease--selection of patients.
Hepato-gastroenterology 1999;46(30):3053-9.
1999: C-Thomas Bock; Hans L Tillmann; Michael P Manns; Christian Trautwein
The pre-S region determines the intracellular localization and appearance of hepatitis B virus.
Hepatology (Baltimore, Md.) 1999;30(2):517-25.
1999: Elmar Jaeckel; Hans L Tillmann; Michael P Manns
Liver transplantation and autoimmunity.
Acta gastro-enterologica Belgica 1999;62(3):323-9.
1999: Hans L Tillmann; Christian Trautwein; T Bock; Klaus H W Böker; Elmar Jäckel; M Glowienka; K Oldhafer; I Bruns; Josée Gauthier; Lynn Condreay; H R Raab; Michael P Manns
Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation.
Hepatology (Baltimore, Md.) 1999;30(1):244-56.
1998: EG Rambusch; Björn Nashan; Hans L Tillmann; Klaus H W Böker; Hans J Schlitt; HG Maschek; Rudolf Raab; Michael P Manns
[De novo hepatitis B infection after liver transplantation--evidence for the need of active hepatitis B vaccination of liver transplantation candidates].
Zeitschrift für Gastroenterologie 1998;36(12):1027-35.
1998: Antonio Ascione; Massimo De Luca; C Canestrini; Giovan Giuseppe Di Costanzo; G Raimondo; G Longo; M P Manns; Hans L Tillmann; G B Forte; P Rocco; O Biceglia; Domenico Faleo; F Vinelli; E M Cela; Lucio Amitrano; Luigi Addario; T Gigliotti
Efficacy of high dose of recombinant alpha 2b interferon on long term response in chronic hepatitis C and cirrhosis: prospective randomized multicentre study.
Italian journal of gastroenterology and hepatology 1998;30(5):517-23.
1998: Hans L Tillmann; S Heringlake; Christian Trautwein; D Meissner; B Nashan; Hans J Schlitt; J Kratochvil; J Hunt; X Qiu; S C Lou; Rudolf Pichlmayr; Michael P Manns
Antibodies against the GB virus C envelope 2 protein before liver transplantation protect against GB virus C de novo infection.
Hepatology (Baltimore, Md.) 1998;28(2):379-84.
1998: H Wedemeyer; Johann Ockenga; H Frank; Hans L Tillmann; A Schuler; Martin Caselitz; Michael Gebel; C Trautwein; Michael P Manns
Perihepatic lymphadenopathy: a marker of response to interferon alpha in chronic hepatitis C.
Hepato-gastroenterology 1998;45(22):1062-8.
1998: S Heringlake; J Ockenga; Hans L Tillmann; Christian Trautwein; D Meissner; Matthias Stoll; J Hunt; CK Jou; N Solomon; Reinhold E Schmidt; Michael P Manns
GB virus C/hepatitis G virus infection: a favorable prognostic factor in human immunodeficiency virus-infected patients?
The Journal of infectious diseases 1998;177(6):1723-6.
1998: EG Rambusch; Heiner Wedemeyer; Hans L Tillmann; S Heringlake; Michael P Manns
[Significance of coinfection with hepatitis G virus for chronic hepatitis C--a review of the literature].
Zeitschrift für Gastroenterologie 1998;36(1):41-53.
1997: DF Chen; LT Pastucha; Ekkehard D Albert; I Seibert; A Volgger; Z Yao; C D Pein; Hans L Tillmann; Michael P Manns; W Stangel
A novel DRB1*0801 haplotype carrying DRB3*0202 found in a German pedigree.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics 1997;24(6):435-7.
1997: C-Thomas Bock; Hans L Tillmann; H J Maschek; Michael P Manns; Christian Trautwein
A preS mutation isolated from a patient with chronic hepatitis B infection leads to virus retention and misassembly.
Gastroenterology 1997;113(6):1976-82.
1997: J Ockenga; Hans L Tillmann; Christian Trautwein; M Stoll; Michael P Manns; R E Schmidt
Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value.
Journal of hepatology 1997;27(1):18-24.
1997: Johann Ockenga; Matthias Stoll; Hans L Tillmann; Christian Trautwein; Michael P Manns; Reinhold E Schmidt
[Coinfection of hepatitis B and C in HIV-infected patients].
Wiener medizinische Wochenschrift (1946) 1997;147(19-20):439-42.
1997: Hans L Tillmann; F N van Pelt; W Martz; T Luecke; H Welp; F Dörries; A Veuskens; M Fischer; Michael P Manns
Accidental intoxication with methylene dianiline p,p'-diaminodiphenylmethane: acute liver damage after presumed ecstasy consumption.
Journal of toxicology. Clinical toxicology 1997;35(1):35-40.
1997: Klaus H W Böker; G Dalley; Matthias J Bahr; HG Maschek; Hans L Tillmann; Christian Trautwein; K Oldhaver; U Bode; Rudolf Pichlmayr; Michael P Manns
Long-term outcome of hepatitis C virus infection after liver transplantation.
Hepatology (Baltimore, Md.) 1997;25(1):203-10.
1996: S Heringlake; S Osterkamp; Christian Trautwein; Hans L Tillmann; Klaus H W Böker; S Muerhoff; I K Mushahwar; Gerhard Hunsmann; Michael P Manns
Association between fulminant hepatic failure and a strain of GBV virus C.
Lancet 1996;348(9042):1626-9.
1996: DF Chen; W Endres; Volker Kliem; Hans L Tillmann; R Brunkhorst; K M Koch; M P Manns; W Stangel
No significant influence of HLA determinants on susceptibility to hepatitis C virus infection in Caucasian patients with end-stage renal disease.
Liver 1996;16(6):384-9.
1996: Hans L Tillmann; Michael P Manns
Mode of hepatitis C virus infection, epidemiology, and chronicity rate in the general population and risk groups.
Digestive diseases and sciences 1996;41(12 Suppl):27S-40S.
1996: S Heringlake; Hans L Tillmann; P Cordes-Temme; Christian Trautwein; Gerhard Hunsmann; Michael P Manns
GBV-C/HGV is not the major cause of autoimmune hepatitis.
Journal of hepatology 1996;25(6):980-4.
1996: Thomas Mertens; J Köck; Walter Hampl; Hans-Jürgen Schlicht; Hans L Tillmann; K J Oldhafer; M P Manns; Rudolf Arnold
Reactivated fulminant hepatitis B virus replication after bone marrow transplantation: clinical course and possible treatment with ganciclovir.
Journal of hepatology 1996;25(6):968-71.
1996: D F Chen; V Kliem; W Endres; R Brunkhorst; Hans L Tillmann; K M Koch; M P Manns; W Stangel
Relationship between human leukocyte antigen determinants and courses of hepatitis B virus infection in Caucasian patients with end-stage renal disease.
Scandinavian journal of gastroenterology 1996;31(12):1211-5.
1996: Volker Kliem; U van den Hoff; Reinhard Brunkhorst; Hans L Tillmann; J Flik; Michael P Manns; Rudolf Pichlmayr; Karl-Martin Koch; U Frei
The long-term course of hepatitis C after kidney transplantation.
Transplantation 1996;62(10):1417-21.
1996: Christian Trautwein; H Schrem; Hans L Tillmann; Stefan Kubicka; D Walker; Klaus H W Böker; HG Maschek; Rudolf Pichlmayr; Michael P Manns
Hepatitis B virus mutations in the pre-S genome before and after liver transplantation.
Hepatology (Baltimore, Md.) 1996;24(3):482-8.
1996: S Heringlake; Hans L Tillmann; Michael P Manns
New hepatitis viruses.
Journal of hepatology 1996;25(2):239-47.
1996: M Krüger; Hans L Tillmann; Christian Trautwein; U Bode; Karl J Oldhafer; HG Maschek; Klaus H W Böker; C E Broelsch; Rudolf Pichlmayr; Michael P Manns
Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: a pilot study.
Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 1996;2(4):253-62.
1996: S Niesert; U Messner; Hans L Tillmann; Hans-Heinrich Günter; J Schneider; M P Manns
[Prevalence of hepatitis B in pregnancy and selective screening].
Geburtshilfe und Frauenheilkunde 1996;56(6):283-6.
1996: Hans L Tillmann; M Krüger; U Bode; Christian Trautwein
[The problem of viral hepatitis in transplantation medicine].
Der Internist 1996;37(3):240-9.
1996: Hans L Tillmann; M P Manns
Hepatitis C virus infection: diagnosis, natural course and therapy.
Kidney & blood pressure research 1996;19(3-4):215-9.
1996: Barbara Rehermann; Ulrike Seifert; Hans L Tillmann; G Michel; Klaus H W Böker; Rudolf Pichlmayr; Michael P Manns
Serological pattern of hepatitis C virus recurrence after liver transplantation.
Journal of hepatology 1996;24(1):15-20.
1995: Stefan Kubicka; Christian Trautwein; H Schrem; Hans L Tillmann; Michael P Manns
Low incidence of p53 mutations in European hepatocellular carcinomas with heterogeneous mutation as a rare event.
Journal of hepatology 1995;23(4):412-9.
1995: Hans L Tillmann; Christian Trautwein; D Walker; K Michitaka; Stefan Kubicka; Klaus H W Böker; Michael P Manns
Clinical relevance of mutations in the precore genome of the hepatitis B virus.
Gut 1995;37(4):568-73.
1995: B Ringe; Klaus H W Böker; Hans J Schlitt; J Sproviero; Joachim Hundrieser; Hans L Tillmann; Ajay Chavan; P Flemming; Michael Galanski; Rudolf Pichlmayr
Recurrence of hepatitis B virus cirrhosis and hepatocellular carcinoma: an indication for retransplantation?
Clinical transplantation 1995;9(3 Pt 1):190-6.
1995: Christian Trautwein; G Kiral; Hans L Tillmann; H Witteler; G Michel; Michael P Manns
Risk factors and prevalence of hepatitis E in German immigrants from the former Soviet Union.
Journal of medical virology 1995;45(4):429-34.
1994: I Lautenschlager; B Nashan; H J Schlitt; K Hoshino; B Ringe; Hans L Tillmann; M Manns; K Wonigeit; Rudolf Pichlmayr
Different cellular patterns associated with hepatitis C virus reactivation, cytomegalovirus infection, and acute rejection in liver transplant patients monitored with transplant aspiration cytology.
Transplantation 1994;58(12):1339-45.
1994: K Michitaka; Marilena Durazzo; Hans L Tillmann; D Walker; T Philipp; Michael P Manns
Analysis of hepatitis C virus genome in patients with autoimmune hepatitis type 2.
Gastroenterology 1994;106(6):1603-10.
1994: S Krautzig; Hans L Tillmann; Eike Wrenger; M Manns; Karl-Martin Koch; Reinhard Brunkhorst
Hepatitis-C virus (HCV) in peritoneal dialysis.
Clinical nephrology 1994;41(2):120.